Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6995147 | 0.79 | HTT (0.32) | HTT | |
| SCHEMBL21543933 | 0.77 | HTT (0.31) | HTT | |
| SCHEMBL24909676 | 0.73 | ACHE (0.32) | — | |
| SCHEMBL2884058 | 0.70 | CES2 (0.36) | HTT | |
| SCHEMBL7300423 | 0.70 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9218462 | 0.70 | ALDH1A1 (0.34) | ALDH1A1HTT | |
| SCHEMBL123396 | 0.69 | — | — | |
| SCHEMBL24909732 | 0.69 | — | — | |
| SCHEMBL17364902 | 0.69 | — | — | |
| SCHEMBL3583073 | 0.69 | ALDH1A1 (0.33) | ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109964354-B | Nonaqueous electrolyte secondary battery | 松下电器产业株式会社 | 2022-04-29 | — | — | CN | disclosed |
| US-11201355-B2 | Nonaqueous electrolyte secondary battery | PANASONIC CORPORATION (JP) | 2021-12-14 | — | — | US | disclosed |
| US-20190348716-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC CORPORATION (JP) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190348716-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | CLCN2, CCRL2, ACKR3 | ALDH1A1 2171/4885TDP1 3824/4885TSHR 147/4885 |
| US-11201355-B2 | Nonaqueous electrolyte secondary battery | CLCN2, CCRL2, ACKR3 | ALDH1A1 2199/4885TDP1 3843/4885TSHR 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.